- New offerings strengthen access to innovative metabolic and regenerative treatments through a leading medical weight loss clinic in San Angelo, Texas.
San Angelo, Texas, 8th May 2026, ZEX PR WIRE — InShapeMD has announced the expansion of its advanced peptide-based wellness programs, introducing enhanced access to scientifically studied compounds including MOTS-C, BPC-157, CJC-1295, and Tesamorelin.
This development reinforces the clinic’s commitment to delivering modern solutions in peptide therapy for patients seeking improved metabolic health, recovery support, and weight management outcomes.
The expanded program integrates these therapies into structured wellness protocols designed to support individuals pursuing medically supervised health optimization. According to the clinic, the inclusion of these peptides allows for a more tailored approach to care, addressing concerns such as fat metabolism, tissue repair, energy regulation, and age-related hormonal decline.
As demand continues to grow for non-surgical, medically guided interventions, InShapeMD’s enhanced offerings position the clinic as a notable medical weight loss clinic in San Angelo, Texas. The organization emphasized that each treatment plan is developed following comprehensive evaluations to ensure patient safety and appropriate clinical oversight.
The newly emphasized weight loss peptide service incorporates peptides such as MOTS-C, which is being studied for its potential role in metabolic efficiency and cellular energy production.
BPC-157 is included for its regenerative properties in tissue recovery, while CJC-1295 and Tesamorelin are utilized in protocols that may support growth hormone regulation and body composition improvements. Together, these therapies form a comprehensive approach designed to complement existing weight loss peptide injections offered at the clinic.
A spokesperson for InShapeMD stated, “Our goal has always been to bridge advanced medical science with practical patient care. By expanding our peptide therapy offerings, we are giving patients access to innovative options that support long-term wellness goals in a safe, structured clinical environment.”
The clinic noted that all therapies are administered under medical supervision, with individualized treatment plans tailored to patient history, goals, and laboratory findings. The expansion reflects broader trends in regenerative and metabolic medicine, where peptide-based protocols are increasingly being explored as supportive tools in wellness and recovery programs.
Patients seeking weight loss peptide injections or consultation regarding peptide-based treatment options are encouraged to schedule evaluations to determine eligibility and develop personalized care plans. The clinic continues to emphasize education, safety, and evidence-informed practice as core components of its service model.
InShapeMD also highlighted its ongoing investment in patient support systems, including monitoring, follow-up care, and lifestyle guidance to maximize the effectiveness of its weight loss peptide service offerings. The expansion is expected to improve accessibility for individuals in the San Angelo region seeking advanced medical weight management solutions.
As interest in medically supervised wellness programs grows, InShapeMD remains focused on expanding its role as a trusted provider of innovative peptide therapy solutions, integrating clinical expertise with emerging scientific developments.
About InShapeMD
InShapeMD is a medically supervised wellness provider specializing in advanced metabolic and regenerative treatments. As a trusted medical weight loss clinic in San Angelo, Texas, the clinic offers personalized programs including peptide therapy, weight loss peptide service, and weight loss peptide injections, focusing on safe, science-based approaches to long-term health improvement.
Contact Information
Website: www.inshapemdtx.com
Email: info@inshapemdtx.com
Address: 3270 Sherwood Way, San Angelo, TX 76901
Hours: Monday –Thursday 8 am–5 pm, Friday 8 am–12 pm
The Post InShapeMD Expands Advanced Peptide Therapies Featuring MOTS-C, BPC-157, CJC-1295, and Tesamorelin in San Angelo first appeared on ZEX PR Wire
